hur man köper psilocybin legal

hur man köper psilocybin legal
hur man köper psilocybin legal How to Invest in Psychedelics

hur man köper psilocybin legal The psychedelics industry is following in the same projectile footsteps of the cannabis industry and could be on its way to becoming a multi-billion dollar industry with the potential to transform mental health treatments. Researchers from Johns Hopkins and other leading institutions have embraced advancements in psychedelic research which has spawned a growing list of science-based biotech companies focused on further clinical development.

PRESS RELEASE: Paid content from NewMediaWire
How to Invest in Psychedelics
CFN Enterprises Inc
April 29, 2021

The Delic Holdings Inc.
Whitefish, Montana – ( NewMediaWire ) – April 29, 2021 – CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the leading media network dedicated to the global legal cannabis, CBD and psychedelics industries, today announced an article covering The Delic Holdings Inc. (CSE: DELC) (OTCQX: DELCF). hur man köper psilocybin legal

The psychedelics industry is following in the same projectile footsteps of the cannabis industry and could be on its way to becoming a multi-billion dollar industry with the potential to transform mental health treatments. Researchers from Johns Hopkins and other leading institutions have embraced advancements in psychedelic research which has spawned a growing list of science-based biotech companies focused on further clinical development.

ADVERTISEMENT

Let’s take a look at how investors can add exposure to the psychedelics sector and add into their portfolio without having to purchase multiple companies and actively manage their portfolio.

Invest in a Psychedelics ETFs

Exchange-traded funds, or ETFs, are one of the easiest ways for investors to build exposure to different corners of the market into their portfolios. They provide instant diversification to a particular theme with exposure to many different stocks in a single security. At the same time, passive ETFs are typically less expensive to own than actively managed mutual funds.

The Horizons Psychedelic Stock Index ETF became the first exchange-traded fund in Canada to focus on psychedelics with its launch in January. With exposure to 23 publicly traded psychedelics companies, a single share of the ETF provides broad exposure to the entire psychedelics industry with a modest 0.85% expense ratio.

The ETF’s largest holdings include Seelos Therapeutics Inc. at 16.56%, Mind Medicine Inc. at 8.86% and Compass Pathways plc at 8.5%. Aside from the popular psychedelics pure plays, the fund holds large and diversified companies like Johnson & Johnson Inc. and AbbVie Inc.

Many of these companies have been strong performers in recent weeks and months. For example, MindMed shares have more than doubled from less than $3.00 in mid-April to around $6.00 in recent sessions.

Leave a Reply

Your email address will not be published. Required fields are marked *